1.373 makale bulundu

[Hoehn & Yahr scale and MDS-UPDRS Part 3 progression in Parkinson's disease patients: retrospective natural history study using a disease registry].

Watanabe T, Naoi I, Obata R, Baba K, Aino H.

Rinsho Shinkeigaku · 2025-11-15

DOI: 10.5692/clinicalneurol.cn-002132PMID: 41242735

Glycyrrhizin Combined with Electroacupuncture Relieves Parkinson's Disease Progression Through the Inhibition of HMGB1-mediated Microglial Autophagy.

Pang A, Bian H, Fan H, Zhou H, Zou Y, Geng X.

Appl Biochem Biotechnol · 2025-11-11

DOI: 10.1007/s12010-025-05474-zPMID: 41217615

Mettl3/Nrf2 Axis Suppresses Parkinson's Disease Progression via Inhibiting NLRP3-Induced Pyroptosis in Serotonin Neurons.

Wang H, Li P, Liu C.

J Vis Exp · 2025-11-07

DOI: 10.3791/69124PMID: 41284522

Delirium, genetic susceptibility and Parkinson's disease progression: a community- and UK biobank-based matched cohort study.

Li M, Duan W, Feng Y, Wang Z, Hao X, Li S, Sun S, Shi C.

Aging Ment Health · 2025-11-04

DOI: 10.1080/13607863.2025.2581102PMID: 41186289

Serum L-ornitin türevi poliaminler Parkinson hastalığının ilerlemesinin göstergeleridir.

Serum L-ornithine-derived polyamines as indicators of Parkinson disease progression.

LeWitt PA, Li J, Auinger P, Parkinson Study Group DATATOP Investigators.

J Neural Transm (Vienna) · 2025-11-03

DOI: 10.1007/s00702-025-03007-wPMID: 41182351

Melatonin Reseptör Agonist ve Antagonistlerin 6-OHDA İndüklenmiş Parkinson Hastalığı Sıçan Modelindeki Hastalık İlerlemesine Etkileri ve Mekanizmaları.

Effects and Mechanisms of Melatonin Receptor Agonist and Antagonist on Disease Progression in a 6-OHDA-Induced Parkinson's Disease Rat Model.

Lin R, Liu P, Lin W, Lin J, Huang L, Lin L.

J Integr Neurosci · 2025-11-01

DOI: 10.31083/jin45522PMID: 41351439

Parkinson hastalığının ilerlemesinin değiştirilmesinde fiziksel aktivitenin rolünü değerlendiren uzunlamasına çalışma.

Longitudinal study evaluating the role of physical activity in modifying Parkinson's disease progression.

Rathod DC, Kurdikar SU, Ratnala M, Arvindsinh RN, Goyal P.

Bioinformation · 2025-10-31

DOI: 10.6026/973206300213612PMID: 41623826

Accelerated Progression of Gait Impairment in Parkinson's Disease and REM Sleep Without Atonia.

Amundsen-Huffmaster SL, Chung JW, Linn-Evans ME, Petrucci MN, Lu C, Weaver DJ, De Kam J, Cooper SE, Tuite PJ, Videnovic A, Howell MJ, MacKinnon CD.

Ann Clin Transl Neurol · 2025-10-28

DOI: 10.1002/acn3.70214PMID: 41150904

Parkinson hastalığındaki bireysel nörodejeneratif ilerlemeyi normatif modelleme yoluyla anlamak.

Understanding individual neurodegenerative progression in Parkinson's disease through normative modelling.

Fraza C, Bučková BR, Johansson ME, Helmich RC, Marquand AF, Beckmann CF.

Sci Rep · 2025-10-21

DOI: 10.1038/s41598-025-20484-xPMID: 41120561

Parkinson hastalığında koku alma ile ilgili beyin bölgelerinde yapısal ve difüzyon görüntüleme: klinik ilerlemenin tahmincileri.

Structural and diffusion imaging in olfactory-related brain regions in Parkinson's disease: predictors of clinical progression.

Hosseini SM, Sohrabi-Ashlaghi A, Kolahi S, Azizi N, Borooghani H, Gharaylou Z, Raminfard S, Ghanaati H, Abbastabar H, Jalali AH, Shakiba M, Ghavami N, Firouznia K.

Sci Rep · 2025-10-13

DOI: 10.1038/s41598-025-19551-0PMID: 41083685

Parkinson hastalığı olan hastalar arasında klinik bir deneme ortamında hastalık ilerlemesini ve tedavi etkilerini değerlendirmek için kompozit ölçeklerin geliştirilmesi.

Development of composite scales for assessing disease progression and treatment effects among patients with Parkinson's disease in a clinical trial setting.

L'Italien G, Rogula B, Powell LC, Potashman M, Dickson SP, Kozauer N, O'Keefe P, Korol EE, Crabtree M, Nagase F, Coric V, Dubow J, Rosenthal LS, Hendrix S, CPP Integrated Parkinson's Database.

Parkinsonism Relat Disord · 2025-10-10

DOI: 10.1016/j.parkreldis.2025.108077PMID: 41106090

Pennsylvania Üniversitesi Gözden geçirilmiş Koku Tanımlama Testi için yüzdelik puanlar 16.972 bireyler için 60 yaş ve üstü.

Percentile scores for the revised University of Pennsylvania Smell Identification Test for 16,972 individuals 60 years of age and older.

Pierz KA, Aamodt W, Gochanour C, Kurth R, Brumm MC, Coffey CS, Heathers LE, Totten M, Doty RL, Marek K, Siderowf A, Parkinson’s Progression Markers Initiative.

NPJ Parkinsons Dis · 2025-10-01

DOI: 10.1038/s41531-025-01095-9PMID: 41034300